Resources
About Us
Meticulous Research®– leading global market research company published a research report titled “Nepal IVD Market By Product (Kits, Instruments, Software), Technology (Immunoassay, Hematology, Coagulation, Diabetes, Molecular), Application (Infectious Diseases, Cardiology, Oncology), Customer Type (Hospital, Diagnostic Lab, Home Care) - Forecast to 2029.”
According to this latest publication from Meticulous Research®, the Nepal in-vitro diagnostics market is expected to grow at a CAGR of 12.3% from 2022 to reach $62.7 million by 2029. The high growth of the Nepal in-vitro diagnostics market is mainly attributed to the increasing prevalence of communicable & non-communicable diseases and the growing number of initiatives for strengthening the country’s healthcare ecosystem. However, the low accessibility & uneven distribution of healthcare services restrain the growth of this market. Additionally, the rising demand for quality healthcare in the country is expected to create market growth opportunities. However, the shortage of healthcare professionals is a major challenge for market growth.
The Nepal in-vitro diagnostics market study presents historical market data in terms of values (2020 and 2021), estimated current data (2022), and forecasts for 2029- by Product (Reagent, Assays, and Kits, Instruments/Analyzers, and Software & Services), Technology (Immunoassay, Clinical Chemistry, Diabetes/Glucose Monitoring, Molecular Diagnostics, Hematology, Coagulation & Hemostasis, Urinalysis, Electrolyte Analysis, and Other Technologies), Application (Infectious Diseases, Diabetes, Oncology, Cardiology, and Other Applications), Customer Type (Hospital Laboratories, Clinical Laboratories, Home Care/Self-testing, and Other Customer Types). The study also evaluates industry competitors in Nepal.
Based on product, in 2022, the reagents, assays, and kits segment is estimated to account for the largest share of the Nepal in-vitro diagnostics market. The key factors attributed to this segment's large market share are increased adoption and recurring purchase of IVD kits and reagents, increased accessibility to disease-specific kits for the early diagnosis of chronic diseases, and technological advancements in IVD tests. According to a journal (International Health, January 2021) published by Oxford University Press, chronic diseases are responsible for 66% of all deaths in Nepal. Thus, the large burden of chronic diseases and the increasing need for the early diagnosis of diseases are expected to drive the demand for IVD reagents, assays, and kits in Nepal.
Based on technology, the immunoassay segment is estimated to account for the largest share of this market in 2022. Factors contributing to the large share of this segment include the higher preference for immunodiagnostic tests by practitioners due to their high accuracy, inherent specificity, high throughput, high sensitivity, and the emergence of advanced diagnostic immunoassay formats. Furthermore, the increased use of immunoassays in point-of-care infectious disease testing, the development of novel tests, and the shift towards miniaturized devices contribute to the large market share of this segment. Immunoassays find application in cancer markers, diagnosing infectious diseases, cardiac analysis, therapeutic drug monitoring, and allergen tests. Therefore, the high prevalence of chronic and infectious diseases calls for the adoption of immunoassays for diagnosis.
Based on application, the infectious diseases segment is estimated to account for the largest share of the market in 2022. The increased accessibility to infectious disease diagnosis in the country is the reason for the largest share of this segment. The COVID-19 pandemic played a major role in increasing the testing capabilities for infectious diseases in the country. For instance, on 25th July 2022, 1,125,682 COVID-19 cases were reported in Nepal. According to the Ministry of Health and Population (MoHP), Nepal, among the 3,048 PCR (polymerase chain reaction) and 1,716 antigen samples, 453 PCR and 115 antigen samples tested positive for COVID-19.
Based on customer type, the Nepal in-vitro diagnostics market is segmented into hospital laboratories, clinical laboratories, home care/self-testing, and other customer types. In 2022, the hospital laboratories segment is estimated to account for the largest share of the Nepal in-vitro diagnostics market. Hospital laboratories continue to upgrade their testing and treatment facilities to make their services competitive by regularly importing modern medical equipment. Furthermore, the pandemic increased the need for diagnostic tests to screen for COVID-19 infections in hospitals and clinics before admission, even for other diseases, surgeries, or usual outpatient visits.
Download Sample Copy Here: https://www.meticulousresearch.com/download-sample-report/cp_id=5356
Key Players
This research report also analyzes and provides a comprehensive analysis of major distributors of IVD products in Nepal. The key players operating in the Nepal in-vitro diagnostics market are F. Hoffman-La Roche Ltd (Switzerland), Thermo Fisher Scientific Inc. (U.S.), Abbott Laboratories (U.S.), Danaher Corporation (U.S.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Accurex Biomedical Pvt. Ltd (India), and Siemens Healthineers AG (Germany).
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
India VNA & PACS Market to Reach $341.6 Million by 2031
Read MoreChina Microarray Market to Be Worth $910.4 Million by 2031
Read MoreChina Neurogenomics Market to Reach $562.1 Million by 2031
Read MoreELISA Market to be Worth $32.69 Billion by 2031
Read MoreDNA Sequencing Market to be Worth $21.30 Billion by 2031
Read MoreOral Care Market to be Worth $58.99 Billion by 2031
Read MoreSpirometer Market to be Worth $1.80 Billion by 2031
Read MorePet Care Market to be Worth $287.96 Billion by 2031
Read MoreRegenerative Medicine Market to be Worth $37.27 Billion by 2031
Read MoreHemostats Market to be Worth $5.32 Billion by 2031
Read MoreBioreactors Market to be Worth $39.96 Billion by 2031
Read MoreProtein Assays Market to be Worth $4.36 Billion by 2031
Read MoreVeterinary API Market to Reach $15.84 Billion by 2031
Read MoreAsia-Pacific NGS Automation Market to be Worth $371 Million by 2031
Read MoreLatin America NGS Market to be Worth $765.2 Million by 2031
Read MoreBiochemical Reagents Market to be Worth $39.61 Billion by 2031
Read MoreMicroarray Kits Market to be Worth $2.51 Billion by 2031
Read MoreAntibody Production Market to Reach $58.35 Billion by 2031
Read MoreMiddle East IVD Market to be Worth $2.15 Billion by 2031
Read MoreSpatial Genomics Market to be Worth $3.23 Billion by 2031
Read MoreAsia-Pacific IVD Market to be Worth $36.02 Billion by 2031
Read MoreEurope NGS Market to be Worth $6.40 Billion by 2030
Read MoreLab Automation Market to be Worth $11.31 Billion by 2031
Read MoreBioinformatics Market to Reach $31.71 Billion by 2031
Read MoreEurope IVD Market to be Worth $39.77 Billion by 2030
Read MoreSequencing Kits Market to be Worth $25.29 Billion by 2031
Read MoreVeterinary API Market to Reach $15.84 Billion by 2031
Read MoreSample Preparation Market to be Worth $12.77 Billion by 2031
Read MoreSurgical Robots Market Worth $25.47 Billion by 2030
Read MoreMedical Coatings Market Worth $3.32 Billion by 2030
Read MoreLiquid Handling Systems Market Worth $6.99 Billion by 2029
Read MoreElectrosurgery Market to be Worth $8.99 Billion by 2031
Read MoreRadiation Dose Management Market Worth $749.1 Million by 2029
Read MoreMolecular Diagnostics Market Worth $46.69 Billion by 2030
Read MoreNewborn Screening Market to be Worth $2.69 Billion by 2031
Read MorePharmacogenomics Market to be Worth $19.5 Billion by 2031
Read MoreDental Practice Management Software Market Worth $ 3.11 Billion by 2029
Read MoreNepal IVD Market Worth $62.7 Million by 2029
Read MorePharmaceutical Contract Packaging Market Worth $42.03 Billion by 2029
Read MoreIndonesia IVD Market Worth $1.11 Billion by 2029
Read MoreMedical Waste Management Market Worth $17.02 billion by 2030
Read MoreEmpty Capsules Market Worth $4.47 Billion by 2029
Read MoreClear Aligners Market to be worth $18.8 Billion by 2030
Read MoreHLA Typing Market Worth $1.9 Billion by 2029
Read MoreReal-world Data Market Worth $1.66 billion by 2029
Read MoreTrack and Trace Solutions Market Worth $27.27 billion by 2029
Read MoreSurface Disinfectant Market Worth $9.52 Billion by 2029
Read MoreElectronic Lab Notebook Market Worth $787.7 million by 2029
Read MoreRapid Diagnostics Market to be Worth $22.65 Billion By 2031
Read MorePlasma Therapy Market Worth $882.5 Million by 2028
Read MorePeripheral Vascular Devices Market Worth $12.02 Billion by 2028
Read MoreBiomaterials Market to Reach 128.7 Billion USD by 2023
Read MoreVaccine Storage Equipment Market Worth $1.83 billion by 2027
Read MorePlasma Fractionation Market Worth $46.9 Billion by 2029
Read MoreHome Healthcare Market to be Worth $514.5 Billion by 2030
Read MoreCardiac Pacemaker Devices Market Worth $4.34 Billion by 2028
Read MoreEuropean Laboratory Informatics Market Worth $1,084.3 Million By 2024
Read MoreCompetent Cells Market Worth 2,318.6 Million USD By 2023
Read MoreCancer Immunotherapy Market to be Worth $267.2 Billion by 2030
Read MoreMultimodal Imaging Market Worth $1.6 Billion By 2024
Read MorePulse Lavage Market to be Worth $661.1 Million by 2030
Read MoreMedical Cooling Systems Market Worth $2.8 Billion By 2024
Read MoreTissue Diagnostics Market Worth $8.52 Billion by 2029
Read MoreEndoscopy Equipment Market Worth $59.8 Billion by 2029
Read MoreAfrican Forensic DNA Testing Market Worth $136.3 Million by 2025
Read MoreClinical Trial Supplies Market to be Worth $5.59 Billion by 2031
Read MoreInfection Control Market Worth $58.2 Billion by 2027
Read MoreSleep Apnea Devices Market Worth $12.9 billion by 2027
Read MoreMedical 3D Printing Market To Reach $983.2 Million By 2020
Read MoreGenomics Market to be Worth $70.52 Billion by 2031
Read MoreAnalytical Standards Market Worth $2.66 Billion By 2027
Read MoreTelehealth Market Worth $539.73 Billion by 2029
Read MoreCell Culture Market Worth $48.63 Billion by 2029
Read MoreAntimicrobial Coatings Market to be Worth $12.41 Billion by 2031
Read MoreFlow Cytometry Market Worth $6.4 Billion by 2027
Read MoreMedical Aesthetics Market Worth $29.43 billion by 2029
Read MoreOligonucleotide Synthesis Market Worth $3.9 Billion by 2025
Read MoreIn Vitro Diagnostics Market to be Worth $116.28 Billion by 2031
Read MoreDental Implants Market Worth $6.52 Billion by 2029
Read MoreActive Implantable Devices Market Worth 24.02 Billion USD By 2022
Read MoreVentilators Market to be Worth $13.23 Billion by 2031
Read MoreDialysis Market to be Worth $36.6 Billion by 2031
Read MorePlasmapheresis Market to be Worth $2.55 Billion by 2030
Read MoreDiabetes Care Devices Market Worth $31.9 Billion by 2028
Read MoreClinical Genomics Market Worth 879.0 Million USD By 2023
Read MoreIVD Quality Control Market to be Worth $2.28 Billion by 2031
Read MoreLaboratory Informatics Market Worth $6.1 Billion by 2030
Read MoreChromatography Data Systems Market to be Worth $1.7 billion by 2030
Read MoreBone Growth Stimulators Market Worth $1.94 Billion by 2030
Read MoreDigital Diabetes Market worth $12.03 billion by 2025
Read MoreTrocars Market Worth $968.5 Million by 2024
Read MoreHealthcare Virtual Assistant Market Worth $1.76 Billion By 2025
Read MoreEurope Hospital Beds Market to be Worth $2.09 Billion by 2030
Read MoreImmunoassay Market Worth $46.49 Billion by 2028
Read MoreHospital Beds Market Worth $ 6.66 Billion by 2030
Read MoreUrinalysis Market Worth $2.19 billion by 2027
Read MoreMedical Image Management Market Worth $7.22 billion by 2030
Read MoreBreast Imaging Market Worth $7.08 Billion by 2027
Read MoreVNA & PACS Market to be Worth $6.50 Billion by 2031
Read More